Certified by Founder Lodge 
                                        
                                        Vedanta Biosciences, Inc.
 
                                                 United States  -  Cambridge, MA 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $106,500,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2010
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            The trillions of microbes that call us home –the human microbiome – perform critical functions that preserve our health including helping develop our immune system, manufacturing nutrients su
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| April, 26 ,2023 | Unknown | $106,500,000 | 
                                                
 Korea Investment Partners
                                                                                
                                                                            
 Hambro Perks
                                                                                
                                                                            
 Seventure Partners
                                                                                
                                                                            
 Pfizer
                                                                                
 Revelation Partners
                                                                                
 K2 HealthVentures
                                                                                
 PEAK6
                                                                                
 QUAD Investment Management
                                                                                
 PureTech Health
                                                                                
 Korea Investment & Securities Co., Ltd
                                                                                
 Reimagined Ventures
                                                                                
 Skyviews Life Science
                                                                                
                                                                            
 AMR Action Fund
                                                                                
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)